CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors
Year: 2017
Type: article
Source: Blood
Authors: Amy Hughes, Jade Clarson, Carine Tang, Ljiljana Vidovic, Deborah L. White, Timothy P. Hughes, Agnes S. M. Yong
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2564723173
